Targeting NQO1 as a Potential Anticancer Strategy Using the Small Molecule Deoxynyboquinone

被引：1
|
作者：
Parkinson, E. I. [1 ]
Bair, J. S. [2 ]
Bey, E. A. [3 ]
Boothman, D. A. [3 ]
Hergenrother, P. J. [1 ]
机构：
[1] Univ Illinois, Urbana, IL 61801 USA
[2] Univ Calif Berkeley, Berkeley, CA 94720 USA
[3] UT SW Med Ctr, Dallas, TX USA
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
10.1016/S0959-8049(12)72294-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
496
引用
收藏
页码：154 / 154
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics and derivation of an anticancer dosing regimen for the novel anti-cancer agent isobutyl-deoxynyboquinone (IB-DNQ), a NQO1 bioactivatable molecule, in the domestic felid species
    Alycen P. Lundberg
    Joshua M. Francis
    Malgorzata Pajak
    Elizabeth I. Parkinson
    Kathryn L. Wycislo
    Thomas J. Rosol
    Megan E. Brown
    Cheryl A. London
    Levent Dirikolu
    Paul J. Hergenrother
    Timothy M. Fan
    Investigational New Drugs, 2017, 35 : 134 - 144
  • [2] Pharmacokinetics and derivation of an anticancer dosing regimen for the novel anti-cancer agent isobutyl-deoxynyboquinone (IB-DNQ), a NQO1 bioactivatable molecule, in the domestic felid species
    Lundberg, Alycen P.
    Francis, Joshua M.
    Pajak, Malgorzata
    Parkinson, Elizabeth I.
    Wycislo, Kathryn L.
    Rosol, Thomas J.
    Brown, Megan E.
    London, Cheryl A.
    Dirikolu, Levent
    Hergenrother, Paul J.
    Fan, Timothy M.
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (02) : 134 - 144
  • [3] Efficient NQO1 Substrates are Potent and Selective Anticancer Agents
    Parkinson, Elizabeth I.
    Bair, Joseph S.
    Cismesia, Megan
    Hergenrother, Paul J.
    ACS CHEMICAL BIOLOGY, 2013, 8 (10) : 2173 - 2183
  • [4] Targeting HIF-1α Function in Cancer through the Chaperone Action of NQO1: Implications of Genetic Diversity of NQO1
    Salido, Eduardo
    Timson, David J.
    Betancor-Fernandez, Isabel
    Palomino-Morales, Rogelio
    Anoz-Carbonell, Ernesto
    Pacheco-Garcia, Juan Luis
    Medina, Milagros
    Pey, Angel L.
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (05):
  • [5] Cisplatin enhances the anticancer effect of β-lapachone by upregulating NQO1
    Terai, Kaoru
    Dong, Guang-Zhi
    Oh, Eun-Taex
    Park, Moon-Taek
    Gu, Yeunhwa
    Song, Chang Won
    Park, Heon Joo
    ANTI-CANCER DRUGS, 2009, 20 (10) : 901 - 909
  • [6] NQO1 activation: a novel antihypertensive treatment strategy?
    Hale, Taben M.
    JOURNAL OF HYPERTENSION, 2014, 32 (02) : 233 - 235
  • [7] Virtual Screening for Potential Phytobioactives as Therapeutic Leads to Inhibit NQO1 for Selective Anticancer Therapy
    Shreevatsa, Bhargav
    Dharmashekara, Chandan
    Swamy, Vikas Halasumane
    Gowda, Meghana V.
    Achar, Raghu Ram
    Kameshwar, Vivek Hamse
    Thimmulappa, Rajesh Kumar
    Syed, Asad
    Elgorban, Abdallah M.
    Al-Rejaie, Salim S.
    Ortega-Castro, Joaquin
    Frau, Juan
    Flores-Holguin, Norma
    Shivamallu, Chandan
    Kollur, Shiva Prasad
    Glossman-Mitnik, Daniel
    MOLECULES, 2021, 26 (22):
  • [8] Human NQO1 as a Selective Target for Anticancer Therapeutics and Tumor Imaging
    Khan, A. E. M. Adnan
    Arutla, Viswanath
    Srivenugopal, Kalkunte S.
    CELLS, 2024, 13 (15)
  • [9] Oncocidia: a small molecule dual targeting pan-anticancer theragnostic strategy
    Ni, Yicheng
    CANCER RESEARCH, 2014, 74 (19)
  • [10] Evaluation of NQO1 as a potential diagnostic marker for bladder cancer
    Cuff, Simone
    Lewis, Ruth
    Jaffar, Mohammed
    Knox, Richard
    Weeks, Ian
    CANCER RESEARCH, 2015, 75
12345